NEW Enterprise Associates 13 L.P., 10% Owner at Ra Pharmaceuticals, Inc. (RARX), sold 435 shares at $13.00 ($6K) on 2016-10-31, disclosed to the SEC on 2016-10-31.
Open-market purchase of $6k RARX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TSRO | BUY | 2018-03-06 | $6.7M | — | Filing → |
| EPZM | BUY | 2016-01-12 | $10.0M | — | Filing → |
| DERM | BUY | 2014-10-08 | $1.1M | — | Filing → |